Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Preferred Shares (2018 - 2019)

Precision Biosciences (DTIL) has disclosed Preferred Shares for 2 consecutive years, with $2000.0 as the latest value for Q1 2019.

  • On a quarterly basis, Preferred Shares changed N/A to $2000.0 in Q1 2019 year-over-year; TTM through Mar 2019 was $2000.0, a N/A change, with the full-year FY2018 number at $3000.0, changed N/A from a year prior.
  • Preferred Shares was $2000.0 for Q1 2019 at Precision Biosciences, down from $3000.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $3000.0 in Q4 2018 to a low of $2000.0 in Q1 2019.